HOME
Investor Relations
Press Release (2012)
2012/01/30
Shionogi Establishes a Developmental Subsidiary in EU
2012/01/25
Shionogi Inc. Press Release: STUDY DATA SHOW CUVPOSA® REDUCED CHRONIC SEVERE DROOLING IN PATIENTS AGES 3-16 YEARS-OLD WITH NEUROLOGIC CONDITIONS
2012/01/18
Shionogi Receives Approval of Injectable Analgesics for Cancer Pain, "OxiFast® Injection 10mg" and "OxiFast® Injection 50mg"
To view these files you must have the Adobe Reader installed on your system. Adobe Reader is availabe for free from the Adobe website. To download and install the software please click on the button.
Press Release
Press Release Backnumber
Financial Highlights
Financial Data
Annual Report
IR Calendar
Conferences and Presentaions
Pipeline
General Meeting of Shareholders
Disclosure Policy
Search
Japanese
sitemap
